Anecortave

Jump to navigation Jump to search
Anecortave
Clinical data
Pregnancy
category
  • ?
Routes of
administration
intravitreal depot injection
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability?
Metabolism?
Elimination half-life?
Excretion?
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC23H30O5
Molar mass386.48

Anecortave (rINN) (Template:PronEng) is a novel angiogenesis inhibitor used in the treatment of the exudative (wet) form of age-related macular degeneration. Although based on a steroid nucleus, it possesses little glucocorticoid activity. It is marketed by Alcon as anecortave acetate for depot suspension under the trade name Retaane.

External links

Template:Pharma-stub